BRISTOL-MYERS SQUIBB COMPANY Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2011-12-31 was 8.00M shares, a 700.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2011-09-30 was 5.00M shares, a 0.00% change year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2011-06-30 was 8.00M shares, a 700.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2011-03-31 was 7.00M shares, a 16.67% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2011 was 28.00M shares, a 115.38% increase from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2010 was 13.00M shares, a 225.00% increase from fiscal 2009.
- BRISTOL-MYERS SQUIBB COMPANY shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2009 was 4.00M shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2011-12-31 | 8.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | 28.00M shares 10-K · filed 2012-02-17 |
| 2011-09-30 | 5.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | 21.00M shares derived: sum of 4 quarters · filed 2012-02-17 |
| 2011-06-30 | 8.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | 21.00M shares derived: sum of 4 quarters · filed 2012-02-17 |
| 2011-03-31 | 7.00M shares 10-Q · filed 2011-04-28 | 14.00M shares derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-12-31 | 1.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | 13.00M shares 10-K · filed 2012-02-17 |
| 2010-09-30 | 5.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | 14.00M shares derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | 1.00M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | |
| 2010-03-31 | 6.00M shares 10-Q · filed 2011-04-28 | |
| 2009-12-31 | 2.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | 4.00M shares 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |